首页> 外文期刊>Annals of Surgical Oncology >Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer
【24h】

Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer

机译:淋巴结阳性和未切除腋窝淋巴结的比率是非转移性淋巴结阳性乳腺癌患者总体生存的独立预后因素

获取原文
获取原文并翻译 | 示例
       

摘要

The status of the axillary lymph nodes in nonmetastatic lymph node-positive breast cancer (BC) patients remains the single most important determinant of overall survival (OS). Although the absolute number of nodes involved with cancer is important for prognosis, the role of the total number of excised nodes has received less emphasis. Thus, several studies have focused on the utility of the axillary lymph node ratio (ALNR) as an independent prognostic indicator of OS. However, most studies suffered from shortcomings, such as including patients who received neoadjuvant therapy or failing to consider the use of adjuvant therapy and tumor receptor status in their analysis.
机译:非转移性淋巴结阳性乳腺癌(BC)患者的腋窝淋巴结状况仍然是整体存活率(OS)的最重要决定因素。尽管与癌症有关的淋巴结的绝对数目对于预后很重要,但切除的淋巴结总数的作用受到的重视较少。因此,一些研究集中在腋窝淋巴结比率(ALNR)作为OS的独立预后指标的实用性上。但是,大多数研究都有缺点,例如包括接受新辅助治疗或在分析中未考虑使用辅助治疗和肿瘤受体状态的患者。

著录项

  • 来源
    《Annals of Surgical Oncology》 |2009年第12期|3388-3395|共8页
  • 作者单位

    Department of Internal Medicine Division of Hematology/Oncology American University of Beirut Medical Center Beirut Lebanon;

    Department of Surgery Division of General Surgery American University of Beirut Medical Center Beirut Lebanon;

    Department of Internal Medicine Division of Hematology/Oncology American University of Beirut Medical Center Beirut Lebanon;

    Department of Internal Medicine Division of Hematology/Oncology American University of Beirut Medical Center Beirut Lebanon;

    Department of Obstetrics and Gynecology American University of Beirut Medical Center Beirut Lebanon;

    School of Pharmacy Lebanese American University Byblos Lebanon;

    Department of Surgery Division of General Surgery American University of Beirut Medical Center Beirut Lebanon;

    Department of Surgery Division of General Surgery American University of Beirut Medical Center Beirut Lebanon;

    Department of Pathology and Laboratory Medicine American University of Beirut Medical Center Beirut Lebanon;

    Department of Pathology and Laboratory Medicine American University of Beirut Medical Center Beirut Lebanon;

    Department of Radiation Oncology American University of Beirut Medical Center Beirut Lebanon;

    Department of Internal Medicine Division of Hematology/Oncology American University of Beirut Medical Center Beirut Lebanon;

    Department of Internal Medicine Division of Hematology/Oncology American University of Beirut Medical Center Beirut Lebanon;

    Department of Internal Medicine Division of Hematology/Oncology American University of Beirut Medical Center Beirut Lebanon;

    Department of Internal Medicine Division of Hematology/Oncology American University of Beirut Medical Center Beirut Lebanon;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号